“Emerging data for PT150 and PT157 show promising results in ex-plant models for pancreatic cancer, glioblastoma and treatment-resistant prostate cancer”

ASCO20 Scientific Program Abstract

PT Oncology Drug Platform

Glucocorticoid & Androgen Receptor Antagonist/Modulators for Oncology

National Cancer Institute Study Results on Multiple Cancers

PT150 Oncology Studies

PT157 Oncology Studies​

PT162 Oncology Studies

PT167 Oncology Studies